俄克拉荷马州总检察长起诉制药公司和 PBM 抬高胰岛素价格，给 1 型糖尿病患者造成经济困难。 Oklahoma AG sues drug companies and PBMs for inflating insulin prices, causing financial hardship for Type 1 Diabetes patients.

俄克拉荷马州总检察长 Gentner Drummond 起诉制药公司和处方福利管理者，指控他们非法抬高胰岛素价格，导致过去几十年来胰岛素价格一路飙升。 Oklahoma Attorney General Gentner Drummond sues drug companies and prescription benefit managers, accusing them of unlawfully inflating insulin prices, which have skyrocketed in the past decades. 胰岛素是 1 型糖尿病患者的生活必需品，诉讼称这种价格操纵给许多家庭造成了经济困难。 Insulin is a life necessity for Type 1 Diabetes patients, and the lawsuit claims that this price manipulation causes financial hardship for many families. 诉讼称，胰岛素的生产成本远低于目前的零售价，无保险情况下的零售价为 300 至 700 美元。 The lawsuit alleges that the cost of production for insulin is significantly lower than the current retail prices, which range from $300 to $700 without insurance.